Home

LOUIS J LAVIGNE JR

CIK 1214127 · last filed 2026-06-17

LOUIS J LAVIGNE JR is a corporate insider who has filed 102 SEC Form 4 insider transactions across 10 companies since 2007. The most recent filing, for ALEC, was dated Jun 17, 2026. Across all open-market trades the lifetime net is −$8.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.7M across reported positions. 3 SEC filings were submitted jointly with ARENA PHARMACEUTICALS INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.70M

Companies

10

Total Filings

102

Lifetime Open-Market Net

-$8.64M

Filer Profile

Reported Address
C/O ALLERGAN, INC.
2525 DUPONT DRIVE
IRVINE, CA 92612
Related Filers
ARENA PHARMACEUTICALS INC — 3 joint filings, latest 2006-08-01
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ALEC Director 138,661 $2.47 $342.5K $0 9 2026-06-17
ZYNGA INC (ZNGA) Delisted Director 0 $8.18 $0 $0 34 2022-05-24
ARAY Director 282,329 $0.26 $74.0K $0 17 2020-12-02
DOCU Director 63,888 $65.08 $4.16M $0 3 2019-06-19
Assertio Therapeutics, Inc (ASRT) Delisted Director 972 $23.50 $22.8K $0 1 2019-05-09
NVCR Director 7,403 $16.85 $124.7K $0 4 2018-06-04
Assertio Therapeutics, Inc (DEPO) Delisted Director 4,403 — — $0 8 2018-05-10
ALLERGAN INC (AGN) Delisted Director 18,148 — — -$8.64M 16 2014-12-23
BMC SOFTWARE INC (BMC) Delisted Director 29,215 — — $0 6 2012-07-27
KYPHON INC (KYPH) Delisted Director 300 — — $0 1 2007-08-03

Recent Filings

102 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-17 ALEC Grant (A) +28,700 $0 EDGAR
2025-06-12 ALEC Grant (A) +28,700 $0 EDGAR
2024-06-12 ALEC Grant (A) +35,000 $0 EDGAR
2023-06-15 ALEC Grant (A) +26,250 $0 EDGAR
2022-06-21 ALEC Grant (A) +9,459 $0 EDGAR
2022-05-24 ZYNGA INC (ZNGA) Delisted Disp (D) −284,064 $0 EDGAR
2022-05-19 ZYNGA INC (ZNGA) Delisted Exer (M) +5,548 $0 EDGAR
2022-02-22 ZYNGA INC (ZNGA) Delisted Exer (M) +5,547 $0 EDGAR
2021-11-17 ZYNGA INC (ZNGA) Delisted Exer (M) +5,547 $0 EDGAR
2021-08-18 ZYNGA INC (ZNGA) Delisted Exer (M) +5,547 $0 EDGAR
Showing 1–10 of 102
Page 1 of 11
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.